Clinical and Scientific Advisory Boards

Clinical Advisors and Principle Investigators

1. Rheumatoid Arthritis

• Prof. Michael Weinblatt, Harvard University
• Paul Emery, M.A., M.D., F.R.C.P, University of Leeds UK
• Edward Keystone, F.R.C.P.C., M.D.,  Mount Sinai Medical Center

2. Psoriasis

• Gerald Kruger, M.D.,  University of Utah, School of Medicine
• Alexa Kimball, M.D., Massachusetts General Hospital
• Mark Lebwohl, M.D., Mount Sinai Medical center
• Bruce Strober, M.D., New York University Medical Center

3. Gliobastoma Multiforme

• Patrick Wen, M.D., Dana-Farber Cancer Institute
• James Vredenburgh, M.D., Duke University Medical Center
• Andrew Brenner, M.D., University of Texas, San Antonio

4. Thyroid Cancer

• Keith C. Bible, M.D., Mayo Clinic
• Axel Grothey, M.D., Mayo Clinic
• Candace Kostelec, M.D., Mayo Clinic

5. DSMB Phase I

• Marc Penn, M.D., Ph.D., F.A.C.C., The Cleveland Clinic
• Prof. Michael Motro, M.D., Tel Aviv University

Scientific Advisory Board

1. Inflammatory Diseases

• Prof. Michael Weinblatt, Harvard University
• Prof. Howard Weiner, Harvard University
• Prof. Paul M Ridker, M.D., M.P.H., F.A.C.C., Harvard Medical School
• Prof. Joseph Witztum, University of California, San Diego
• Prof. John J. P. Kastelein, M.D., University of Amsterdam

2. Cancer

• Ernest Borden, M.D., The Cleveland Clinic
• Prof. David Curiel, University of Alabama
• Prof. Robert Langer, Massachusetts Institute of Technology

3. CMC and Development

• Bonnie Goldman, M.D., Ex-Merck and J&J
• Paul Reider, Ph.D., Princeton University , Ex-Merck and Amgen
• Ian Wilding, Ph.D., Nottingham University